Roche is paying Nurix Therapeutics $700 million upfront for rights to bexobrutideg, securing a stake in a BTK degrader that is…

In recent years, the proliferation of power electronic converters in diverse applications—from renewable energy systems to electric vehicles—has underscored the…

In a groundbreaking observational study published recently, researchers have unveiled critical links between the discontinuation of dental care and the…

In a groundbreaking observational study recently published in the esteemed journal Annals of Oncology, researchers have unveiled compelling evidence suggesting…

In a landmark study poised to transform perioperative care for elderly patients, researchers have developed an innovative predictive model that…

In a groundbreaking stride within the realm of nanomedicine and cancer therapy, researchers have unveiled a compelling advancement harnessing the…

Boehringer Ingelheim spent the weekend pointing to survodutide's “targeted” weight loss, but the latest data couldn’t shake off concerns about…

In an era where the complexity of medical regimens in older adults grows exponentially, the challenge of ensuring medication adequacy…

In the ever-evolving world of construction materials, the quest for stronger, more durable, and more efficient building compounds remains paramount.…

Mazdutide, a novel and promising pharmacological agent, has emerged as a potential breakthrough in the management of obesity, a globally…